e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
The relevance of diagnostic and monitoring tools in clinical practice
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased total, secretory and NTHi-specific IgA in the COPD airway
Karl J. Staples (Southampton, United Kingdom), Karl J. Staples, Stephen Taylor, Steve Thomas, Kristoffer Ostridge, Alice Richardson, Andrew C. Tuck, Stuart C. Clarke, Andrew Gorringe, Tom M.A. Wilkinson
Source:
International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Session:
The relevance of diagnostic and monitoring tools in clinical practice
Session type:
Poster Discussion
Number:
567
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Karl J. Staples (Southampton, United Kingdom), Karl J. Staples, Stephen Taylor, Steve Thomas, Kristoffer Ostridge, Alice Richardson, Andrew C. Tuck, Stuart C. Clarke, Andrew Gorringe, Tom M.A. Wilkinson. Increased total, secretory and NTHi-specific IgA in the COPD airway. Eur Respir J 2015; 46: Suppl. 59, 567
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Definition and history of sarcoidosis
Related content which might interest you:
Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Variability of total serum IgE in moderate-to-severe asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Identification of nasal virus infection in patients with COPD exacerbations
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Airway MUC2 is decreased in patients with severe COPD and bacterial colonization
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Outcomes of immunotherapy of patients with COPD
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept